Parabilis Medicines, Inc. Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares
Parabilis Medicines, Inc. (PBLS) reported Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares of 419.51 thousand shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares · last filed 2026-08-13
- Parabilis Medicines, Inc. incremental common shares attributable to dilutive effect of contingently issuable shares for the quarter ending 2026-06-30 was 419.51K shares, a 0.00% change year-over-year.
- Parabilis Medicines, Inc. incremental common shares attributable to dilutive effect of contingently issuable shares for the quarter ending 2025-06-30 was 419.51K shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares 3 month | Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares 6 month |
|---|---|---|
| 2026-06-30 | 419.51K shares 10-Q · filed 2026-08-13 | 419.51K shares 10-Q · filed 2026-08-13 |
| 2025-06-30 | 419.51K shares 10-Q · filed 2026-08-13 | 419.51K shares 10-Q · filed 2026-08-13 |